1. Home
  2. KEQU vs GNLX Comparison

KEQU vs GNLX Comparison

Compare KEQU & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kewaunee Scientific Corporation

KEQU

Kewaunee Scientific Corporation

N/A

Current Price

$36.01

Market Cap

110.9M

Sector

Industrials

ML Signal

N/A

Logo Genelux Corporation

GNLX

Genelux Corporation

HOLD

Current Price

$2.89

Market Cap

133.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KEQU
GNLX
Founded
1906
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
110.9M
133.0M
IPO Year
1995
2022

Fundamental Metrics

Financial Performance
Metric
KEQU
GNLX
Price
$36.01
$2.89
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$17.25
AVG Volume (30 Days)
4.8K
169.4K
Earning Date
03-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
9.47
EPS
3.22
N/A
Revenue
$138,558,000.00
$8,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$11.29
N/A
Revenue Growth
7.72
N/A
52 Week Low
$33.27
$2.29
52 Week High
$60.89
$8.54

Technical Indicators

Market Signals
Indicator
KEQU
GNLX
Relative Strength Index (RSI) 49.17 46.82
Support Level $35.15 $2.73
Resistance Level $41.25 $2.94
Average True Range (ATR) 1.06 0.12
MACD 0.04 -0.00
Stochastic Oscillator 34.40 33.33

Price Performance

Historical Comparison
KEQU
GNLX

About KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.

About GNLX Genelux Corporation

Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.

Share on Social Networks: